Clinical improvement in REDES study stratified by blood eosinophil reduction after mepolizumab treatment
C. Domingo Ribas (Sabadell, Barcelona, Spain), R. Díaz-Campos (Madrid, Spain), T. Hermida-Valverde (Asturias, Spain), E. Arismendi (Barcelona, Spain), D. Bañas Conejero (Madrid, Spain), M. Sánchez-Herrero (Madrid, Spain)
Source: International Congress 2022 – Studies targeting IL-5 pathways in asthma
Session: Studies targeting IL-5 pathways in asthma
Session type: Thematic Poster
Number: 2134
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Domingo Ribas (Sabadell, Barcelona, Spain), R. Díaz-Campos (Madrid, Spain), T. Hermida-Valverde (Asturias, Spain), E. Arismendi (Barcelona, Spain), D. Bañas Conejero (Madrid, Spain), M. Sánchez-Herrero (Madrid, Spain). Clinical improvement in REDES study stratified by blood eosinophil reduction after mepolizumab treatment. 2134
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|